G21S (p.Gly21Ser) variant of NBN (Nibrin)
G21S (p.Gly21Ser) in NBN (Nibrin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Hereditary cancer-predisposing syndrome. The available variant effect predictions contribute to a CATVariant prioritization score of 0.36 / 1. The record also includes published literature and structural context.
G21S (p.Gly21Ser) variant details
- p.Gly21Ser
- rs1586112049
- ClinGen CA371663608
- ClinVar RCV001025001
- Ensembl rs1586112049
- Uncertain significance
- Hereditary cancer-predisposing syndrome
- Missense
- Variant Prioritization Score for Impact Estimate 0.358
- AlphaMissense 0.13
- MetaLR 0.23
- MetaSVM -0.64
- PolyPhen-2 1.00
- SIFT 0.01
- MutPred 0.92
- ClinVar: Uncertain significance (Hereditary cancer-predisposing syndrome)
- EBI: Variant of uncertain significance
- UniProt: Uncertain significance
- Structural context available
- Cited in: A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic… (PMID 25394175)